Category: Drug Safety Alerts
-
Some Antibiotics Linked To Tendon Rupture; Public Citizen Petitions FDA For Stronger Warnings
Targets Fluoroquinolone Class of Antibiotics: Tequin, Levaquin, Cipro, et al. ____________________________________________________________________ UPDATE: For recent developments regarding personal injury lawsuits that involve Levaquin and tendon-related side effects, visit the Levaquin Information page over at our Drug…
-
FDA Approves New, Stronger Warnings For ADHD Drugs
Sudden Deaths, Strokes, And Heart Attacks In Adults At Usual Doses Several drugs to treat attention deficit hyperactivity disorder (ADHD) — including GlaxoSmithKline (GSK) Plc’s Dexedrine, Novartis AG’s Ritalin, Johnson & Johnson’s Concerta, and…
-
Anti-Epileptic Drugs Associated With Birth Defects And Fetal Death
Study Looks At Depakote, Dilantin, Tegretol, And Lamictal An August 8, 2006 article in the Los Angeles Times (LA Times) reports about a recent study involving four popular epilepsy drugs which found that one…
-
Ketek Allegedly “More Toxic Than Most Other Drugs”
Dr. David Graham At FDA Wants An "Immediate Withdrawal" Of Ketek On the morning of July 19, 2006 a National Public Radio (NPR) news piece about Ketek brought our attention back to this increasingly…
-
Association of Sudden Vision Loss / NAION With Erectile Dysfunction (ED) Drugs
A "Dear Doctor" Letter Was Sent In June 2006, But Only In Canada As reported previously, the erectile dysfunction (ED) drugs Cialis (tadalafil), Levitra (vardenafil hydrochloride), and Viagra (sildenafil citrate) have been associated with…
-
Sanofi-Aventis Sending “Dear Doctor” Letter About Ketek Label Changes
Bolded Warning, But Not "Black Box", For Liver Problems And Reports Of Deaths In late June 2006 Sanofi-Aventis SA announced that it had added a new bolded warning about the risks of liver failure…
-
Cox-2 Drugs Increase Risk Of Second Heart Attack Or Death When Used After First Heart Attack
Will June 2006 Circulation Article Affect Lawsuits Involving Bextra, Celebrex, And Vioxx? In mid-June 2006 the medical journal Circulation published online an early-release version of a study which reveals that Bextra, Celebrex, and Vioxx…
-
Ketek: Side-Effects May Outweigh Its Benefits
And Sanofi-Aventis Suspends Enrollment In A Pediatric Clinical Trial In May and June 2006 there was a continuing debate on several levels about whether or not Ketek (telithromycin) should be withdrawn from the market…